BLK

Blackrock
D

BLK

Arincen60/100B

Blackrock executives and insider trading

Laurence Douglas Fink sold 35,805 shares for 37.67M USD in 5 sales over the last twelve months, the last on 16 July 2026, and bought none on the open market.

Over the last twelve months Blackrock's insiders sold 161,060 shares for 175.57M USD in 30 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
30
Shares sold
161,060
Value sold
175.57M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
0
0
6 months
22.00M USD
0
1 year
175.57M USD
0
2 years
475.03M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Laurence Douglas Fink CEOFounder, Chief Executive Officer & Chairman7435,80537.67M USD—16 Jul 2026—
Robert Lawrence Goldstein Senior MD & Chief Operating Officer5259,48364.66M USD—11 Feb 2026—
J. Richard Kushel Senior MD & Head of the Portfolio Management Group5922,38525.08M USD—24 Feb 2026—
Christopher J. Meade General Counsel and CLO—18,09519.94M USD—16 Jul 202632,154
Martin Small Senior MD, Chief Financial Officer & Global Head of Corporate Strategy5014,14916.40M USD—16 Jan 202612,093
Robert Steven Kapito President & Member of Board of Directors708,7399.23M USD—27 Apr 2026—
Stephen Cohen Senior Managing Director—2,4042.58M USD—23 Feb 2026—

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
16 Jul 2026Laurence Douglas FinkSale1,9051,080.572.06M USD223,831Form 4
16 Jul 2026Christopher J. MeadeSale15,8951,101.9917.52M USD16,259Form 4
16 Jul 2026Christopher J. MeadeSale2,2001,102.802.43M USD14,059Form 4
28 Apr 2026Laurence Douglas FinkSale9,7151,049.6110.20M USD254,701Form 4
28 Apr 2026Laurence Douglas FinkSale13,8341,050.4414.53M USD240,867Form 4
28 Apr 2026Laurence Douglas FinkSale8,2251,051.358.65M USD232,642Form 4
28 Apr 2026Laurence Douglas FinkSale2,1261,052.502.24M USD230,516Form 4
27 Apr 2026Robert Steven KapitoSale3,1881,056.103.37M USD215,737Form 4
27 Apr 2026Robert Steven KapitoSale5,3641,056.865.67M USD210,373Form 4
27 Apr 2026Robert Steven KapitoSale1871,057.60197.77K USD210,186Form 4
24 Feb 2026J. Richard KushelSale2,0001,083.052.17M USD61,980Form 4
24 Feb 2026J. Richard KushelSale3851,084.91417.69K USD3,335Form 4
23 Feb 2026Stephen CohenSale2251,069.56240.65K USD5,661Form 4
11 Feb 2026Stephen CohenSale2,1791,073.872.34M USD6,543Form 4
11 Feb 2026Robert Lawrence GoldsteinSale2,3641,083.112.56M USD49,114Form 4

Common questions about Blackrock's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.